HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S R Wayne Chen Selected Research

Polymorphic catecholergic ventricular tachycardia

1/2021Cardiac ryanodine receptor calcium release deficiency syndrome.
1/2021Novel RyR2 Mutation (G3118R) Is Associated With Autosomal Recessive Ventricular Fibrillation and Sudden Death: Clinical, Functional, and Computational Analysis.
1/2021Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death.
1/2018Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
3/2017A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
1/2017CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.
11/2016Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.
11/2016Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.
11/2016Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts.
10/2015Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S R Wayne Chen Research Topics

Disease

22Cardiac Arrhythmias (Arrythmia)
01/2022 - 08/2004
15Polymorphic catecholergic ventricular tachycardia
01/2021 - 07/2010
12Sudden Death
01/2021 - 08/2002
12Heart Failure
11/2016 - 03/2004
10Ventricular Tachycardia
09/2015 - 08/2002
4Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2022 - 11/2005
3Alzheimer Disease (Alzheimer's Disease)
11/2022 - 01/2020
3Ventricular Fibrillation
01/2022 - 11/2007
2Memory Disorders (Memory Loss)
11/2022 - 01/2020
2Channelopathies
01/2022 - 03/2017
2Paroxysmal ventricular fibrillation
01/2021 - 11/2007
2Atrial Fibrillation
01/2021 - 11/2016
2Bradycardia
09/2015 - 01/2014
2Cardiomyopathies (Cardiomyopathy)
03/2015 - 03/2012
1Intellectual Disability (Idiocy)
01/2022
1Familial Sudden Death
01/2022
1Cardiotoxicity
12/2018
1Atherosclerosis
01/2017
1Heart Diseases (Heart Disease)
11/2016
1Long QT Syndrome
10/2015
1Hypotension (Low Blood Pressure)
09/2015
1Cardiomegaly (Heart Hypertrophy)
07/2014
1Hypertrophy
07/2014
1Tachycardia (Tachyarrhythmias)
10/2013
1Atrioventricular Block
01/2013
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
03/2012
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
03/2012
1Syncope (Fainting)
07/2010
1Malignant Hyperthermia
07/2008
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
06/2008
1Bidirectional tachycardia
11/2007
1Myocardial Infarction
01/2006

Drug/Important Bio-Agent (IBA)

48Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
11/2022 - 08/2002
9Carvedilol (Coreg)FDA LinkGeneric
12/2018 - 07/2011
7Phenobarbital (Luminal)FDA Link
12/2016 - 08/2004
5CalciumIBA
01/2022 - 06/2008
5Amino AcidsFDA Link
11/2016 - 03/2004
4tacrolimus binding protein 1BIBA
07/2010 - 03/2004
2Metoprolol (Toprol-XL)FDA LinkGeneric
01/2022 - 07/2011
2Amyloid (Amyloid Fibrils)IBA
11/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2012
2Calmodulin (Calcium-Dependent Activator Protein)IBA
11/2019 - 10/2015
2Caffeine (No Doz)FDA LinkGeneric
11/2016 - 09/2008
2Pharmaceutical PreparationsIBA
01/2016 - 11/2013
2Adrenergic Agents (Adrenergic Drugs)IBA
07/2010 - 05/2006
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
04/2005 - 03/2004
1Flecainide (Tambocor)FDA LinkGeneric
01/2022
1CatecholaminesIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1JNK Mitogen-Activated Protein KinasesIBA
01/2021
1Ouabain (G Strophanthin)IBA
12/2018
1Transcription Factors (Transcription Factor)IBA
01/2017
1ElementsIBA
01/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2017
1LDL Receptors (LDL Receptor)IBA
01/2017
1SterolsIBA
01/2017
1NebivololFDA Link
11/2016
1CalsequestrinIBA
07/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2013
1phospholambanIBA
08/2013
1Bisoprolol (Concor)FDA LinkGeneric
07/2011
1Carrier Proteins (Binding Protein)IBA
07/2010
1Tacrolimus Binding Proteins (FKBP)IBA
08/2007
1RyanodineIBA
06/2007
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2006

Therapy/Procedure

1General Anesthesia
07/2008